Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 34Recruiting 17Unknown 10Active not recruiting 8Terminated 5Withdrawn 3Not yet recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 9Rectal Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Glioblastoma 4Esophageal Neoplasms 4Neoplasms 3Nasopharyngeal Carcinoma 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Adenocarcinoma 2Spinal Cord Neoplasms 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1Rhabdomyosarcoma 1Rectal Cancer Patients 1Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pelvic Neoplasms 1

Interventions

Exercise 9Standard of Care 5trametinib 3tislelizumab 3Radiotherapy 3Radiosurgery 3Palliative Care 3Paclitaxel 3Gemcitabine 3Carboplatin 3130-nm albumin-bound paclitaxel 3trastuzumab deruxtecan 2cemiplimab 2Therapeutics 2Surveys and Questionnaires 2Resistance Training 2Oxaliplatin 2Maintenance 2Immune Checkpoint Inhibitors 2Drug Therapy 2Cisplatin 2Anastrozole 2vedolizumab 1toripalimab 1surufatinib 1sparsentan 1sintilimab 1semaglutide 1posaconazole 1pomalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplasms × Radiotherapy × Clear all
NCT07142200 2025-08-26

DECIDING

RenJi Hospital

Phase 2 Not yet recruiting
45 enrolled
Tumor-Agnostic

Neoplasms

NCT07053735 2025-07-08

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Peking University First Hospital

Phase 1 Not yet recruiting
30 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasms

NCT06558175 2024-08-16

REPAIR

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 1 Not yet recruiting
48 enrolled
GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡